The Vital Role of Monoclonal Antibodies in Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyposis
Allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyposis (CRSwNP) are common inflammatory conditions of the upper airways that significantly impact patients’ quality of life. Though both are distinct upper […]
Posted on
FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis
Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation of the nose and paranasal sinuses which lasts for more than 12 weeks. Signs and symptoms of sinusitis include […]
Posted on
Best practices for Safe Nasal Irrigation
Nasal irrigation, (also termed as nasal rinsing, washout, douching or lavage) is a personal hygiene practice in which a person’s nasal cavity is washed with saline water to flush out […]
Posted on
Recent updates in guidelines for treatment of Seasonal Allergic Rhinitis
The 2017 Joint Task Force on Practice Parameters (JTFPP) comprising representatives from the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the Joint […]
Posted on
Treatment of allergic rhinitis in pregnancy
Allergic rhinitis (AR) affects 20-30% of women in the childbearing age group with an annually increasing prevalence. The classical clinical symptoms include sneezing, itching, nasal blockage, and nasal discharge. In […]
Posted on